BCYC
Price
$6.75
Change
-$0.14 (-2.03%)
Updated
Apr 7 closing price
Capitalization
467.12M
23 days until earnings call
LYRA
Price
$0.11
Change
-$0.01 (-8.33%)
Updated
Apr 7 closing price
Capitalization
7.37M
35 days until earnings call
Ad is loading...

BCYC vs LYRA

Header iconBCYC vs LYRA Comparison
Open Charts BCYC vs LYRABanner chart's image
Bicycle Therapeutics
Price$6.75
Change-$0.14 (-2.03%)
Volume$517.7K
Capitalization467.12M
Lyra Therapeutics
Price$0.11
Change-$0.01 (-8.33%)
Volume$2.48M
Capitalization7.37M
BCYC vs LYRA Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. LYRA commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and LYRA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 08, 2025
Stock price -- (BCYC: $6.89 vs. LYRA: $0.12)
Brand notoriety: BCYC and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 116% vs. LYRA: 432%
Market capitalization -- BCYC: $467.12M vs. LYRA: $7.37M
BCYC [@Biotechnology] is valued at $467.12M. LYRA’s [@Biotechnology] market capitalization is $7.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileLYRA’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • LYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and LYRA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while LYRA’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 3 bearish.
  • LYRA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than LYRA.

Price Growth

BCYC (@Biotechnology) experienced а -23.19% price change this week, while LYRA (@Biotechnology) price change was -13.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.12%. For the same industry, the average monthly price growth was -17.78%, and the average quarterly price growth was -18.34%.

Reported Earning Dates

BCYC is expected to report earnings on May 01, 2025.

LYRA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-9.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($467M) has a higher market cap than LYRA($7.37M). LYRA YTD gains are higher at: -41.570 vs. BCYC (-50.786). LYRA has higher annual earnings (EBITDA): -60.26M vs. BCYC (-164.89M). BCYC has more cash in the bank: 880M vs. LYRA (40.6M). BCYC has less debt than LYRA: BCYC (9.49M) vs LYRA (34.4M). BCYC has higher revenues than LYRA: BCYC (35.3M) vs LYRA (1.53M).
BCYCLYRABCYC / LYRA
Capitalization467M7.37M6,335%
EBITDA-164.89M-60.26M274%
Gain YTD-50.786-41.570122%
P/E RatioN/AN/A-
Revenue35.3M1.53M2,301%
Total Cash880M40.6M2,167%
Total Debt9.49M34.4M28%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCLYRA
RSI
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 7 days ago
88%
MACD
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
88%
Advances
ODDS (%)
Bullish Trend 22 days ago
84%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 7 days ago
89%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.492.39
+11.33%
GameStop Corp
SPY505.28-31.42
-5.85%
SPDR® S&P 500® ETF Trust
BTC.X78214.484000-5290.312500
-6.34%
Bitcoin cryptocurrency
AAPL188.38-14.81
-7.29%
Apple
TSLA239.43-27.85
-10.42%
Tesla

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with INO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-7.27%
INO - BCYC
50%
Loosely correlated
-1.89%
RPTX - BCYC
48%
Loosely correlated
-4.77%
XNCR - BCYC
44%
Loosely correlated
-2.58%
RLAY - BCYC
43%
Loosely correlated
-12.66%
FHTX - BCYC
37%
Loosely correlated
+9.21%
More

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+8.55%
ROQAF - LYRA
85%
Closely correlated
N/A
GLYC - LYRA
76%
Closely correlated
-2.76%
EYPT - LYRA
58%
Loosely correlated
-7.62%
HSTC - LYRA
29%
Poorly correlated
N/A
BCYC - LYRA
27%
Poorly correlated
-7.27%
More